GI bleed - Nursing Case Study
Pathophysiology
• Primary mechanism: Mucosal erosion or ulceration in the gastrointestinal tract, often due to peptic ulcer disease or NSAID use, leads to the disruption of protective barriers and exposure to gastric acids, causing bleeding.
• Secondary mechanism: Vascular abnormalities such as varices, often from portal hypertension in liver cirrhosis, can rupture, leading to significant hemorrhage due to increased pressure and weakened vessel walls.
• Key complication: Anemia and hypovolemic shock can result from significant blood loss, impacting oxygen delivery and requiring urgent intervention to restore hemodynamic stability.
Patient Profile
Demographics:
67-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, type 2 diabetes, peptic ulcer disease
• Current medications: Lisinopril, Metformin, Omeprazole
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Dark, tarry stools for the past 2 days
• Key symptoms: Dizziness, fatigue, abdominal pain, nausea
• Vital signs: Blood pressure 92/60 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F
Section 1
As the emergency department team evaluates the patient, further initial assessment findings reveal notable pallor and diaphoresis, consistent with significant blood loss. The abdominal examination reveals mild tenderness in the epigastric region without rebound tenderness or guarding, suggesting an ongoing but not acute surgical abdomen. The patient's mucous membranes appear dry, indicating possible dehydration. Laboratory results show a hemoglobin level of 8.2 g/dL, down from his baseline of 13.5 g/dL, confirming moderate anemia likely secondary to his gastrointestinal bleed. Blood urea nitrogen (BUN) is elevated at 34 mg/dL, with a creatinine level of 1.2 mg/dL, indicating potential prerenal azotemia due to hypovolemia.
In light of these findings, clinical reasoning focuses on addressing the hypovolemic state and preventing further deterioration. The medical team initiates fluid resuscitation with intravenous crystalloids to stabilize blood pressure and improve perfusion. Crossmatching is ordered in anticipation of a possible blood transfusion to correct anemia and support hemodynamic stability. Given the patient's history of peptic ulcer disease, an urgent endoscopy is scheduled to identify the bleeding source and consider therapeutic interventions such as cauterization or clipping. The differential diagnosis also considers potential variceal bleeding, requiring vigilance for signs of liver cirrhosis or portal hypertension, which would necessitate a different management approach, including vasoactive medications and endoscopic banding.
As the team monitors the patient's response to interventions, they pay close attention to his ongoing vital signs and symptomatology. A repeat blood pressure measurement shows a slight improvement to 98/64 mmHg, suggesting a positive response to fluid administration. However, the patient's heart rate remains elevated at 108 bpm, indicating continued compensatory mechanisms for blood loss. The clinical team remains vigilant for the potential development of new complications, such as rebleeding or hemodynamic instability, which would require further escalation of care, including possible surgical consultation or transfer to intensive care for closer monitoring.
Section 2
As the emergency department team continues to monitor the patient, new diagnostic results arrive, shedding light on the evolving clinical picture. An urgent endoscopy reveals a bleeding gastric ulcer, with visible stigmata of recent hemorrhage. The endoscopist performs successful cauterization of the ulcer, achieving hemostasis. Despite this intervention, the patient's laboratory results indicate ongoing challenges; repeat hemoglobin levels have decreased slightly to 7.9 g/dL, suggesting either continued bleeding prior to cauterization or hemodilution from aggressive fluid resuscitation.
Simultaneously, liver function tests return, showing a mildly elevated alanine aminotransferase (ALT) of 75 U/L and aspartate aminotransferase (AST) of 68 U/L, though these values are not overtly suggestive of significant liver dysfunction. However, the presence of these elevated liver enzymes, combined with the elevated BUN and the patient's history, raises a concern for potential hepatic involvement. This prompts further evaluation for underlying liver disease, including an abdominal ultrasound to assess liver morphology and the presence of any ascites, which could indicate portal hypertension—a complication that may have contributed to the bleeding.
The response to interventions is cautiously optimistic, as the patient's blood pressure stabilizes further to 104/70 mmHg, and he reports a slight decrease in dizziness. Nonetheless, the tachycardia persists with a heart rate of 102 bpm, and the team decides to initiate a transfusion of packed red blood cells to address anemia and improve oxygen delivery. Clinicians remain on high alert for any signs of rebleeding or hemodynamic compromise, prepared to escalate care if necessary. The interdisciplinary team discusses the plan to continue close monitoring in the intensive care unit, anticipating potential additional interventions such as proton pump inhibitor therapy to promote ulcer healing and prevent recurrence.
Section 3
As the patient continues to be monitored in the intensive care unit, there is a noticeable change in his clinical status. Over the next few hours, the patient begins to exhibit increased abdominal pain and distention. A focused abdominal assessment reveals hypoactive bowel sounds, and the patient reports a sensation of fullness and discomfort when palpated. Vital signs show a slight increase in heart rate to 108 bpm, and his blood pressure remains stable but slightly on the lower end at 100/68 mmHg. Although the transfusion of packed red blood cells has improved his hemoglobin to 8.2 g/dL, the persistent tachycardia and new abdominal findings prompt further investigation.
In response to these developments, the interdisciplinary team orders an urgent abdominal CT scan to evaluate the possibility of complications such as perforation or obstruction. The results reveal the presence of moderate ascites and a thickened gastric wall, raising concerns for gastric perforation or peritonitis. Additionally, the CT scan indicates mild splenomegaly and subtle signs of portal hypertension, corroborating earlier suspicions of possible liver involvement. These findings necessitate a refined clinical approach, balancing the management of the acute gastrointestinal bleed with the emerging signs of potential hepatic and abdominal complications.
Given these new complications, the care team decides to initiate broad-spectrum antibiotics to preempt any infectious processes, considering the risk of bacterial translocation due to ascites. The plan includes escalating proton pump inhibitor therapy to ensure maximal ulcer protection, and consultations with gastroenterology and hepatology are requested to address the interplay between the patient's gastric and hepatic issues. The team remains vigilant, closely monitoring for any further decline in the patient's condition, with a readiness to intervene surgically if the situation deteriorates. This proactive approach reflects the need for cohesive clinical reasoning to manage the intricacies of the patient's evolving clinical picture.
Section 4
Response to Interventions:
As the care team implements the newly adjusted treatment plan, the patient is closely monitored for any signs of improvement or further deterioration. Over the next 12 hours, the administration of broad-spectrum antibiotics appears to stabilize the patient, as indicated by a slight reduction in abdominal distention and a decrease in the sensation of fullness upon palpation. However, the patient's heart rate remains elevated at 104 bpm, suggesting ongoing physiological stress. Blood pressure remains stable but low, at 98/66 mmHg, underscoring the need for continued vigilance.
Laboratory tests are repeated to assess the impact of the interventions. The patient's white blood cell count shows a slight decrease from 14,000/mm³ to 12,500/mm³, offering a cautious indication that the antibiotics may be mitigating any underlying infectious process. Liver function tests reveal a mildly elevated bilirubin level of 2.1 mg/dL, with AST and ALT levels showing slight increases, supporting the concern of hepatic involvement. Despite these changes, the patient's hemoglobin level remains stable at 8.1 g/dL, suggesting that the GI bleed is under control for the moment, but further investigation into the hepatic issues is necessary.
Clinically, the patient's mental status remains clear, but he reports persistent fatigue and mild nausea, which the team attributes to the ongoing stress of the condition and its treatment. The interdisciplinary team discusses the potential need for paracentesis to manage the ascites and considers the timing of possible endoscopic intervention to address the gastric issues. The patient's care plan is adjusted to include more frequent monitoring of liver function and close observation for any escalation in clinical symptoms, ensuring readiness to adapt treatment strategies as needed. This continuous evaluation and adjustment highlight the importance of integrated clinical reasoning in managing complex, evolving cases like this one.
Section 5
As the care team continues to monitor the patient closely, a new complication arises. Approximately 18 hours after the initial stabilization, the patient begins to exhibit signs of hepatic encephalopathy, a concerning development given the previous indication of hepatic involvement. The patient becomes slightly confused, showing difficulty with simple arithmetic tasks and demonstrating asterixis, or "liver flap," upon extension of the wrists. This change in mental status prompts an urgent reassessment by the medical team.
New diagnostic results are ordered, including an ammonia level, which returns elevated at 80 µmol/L, confirming the suspicion of hepatic encephalopathy. The patient's liver function tests are repeated, revealing further elevations in bilirubin to 3.5 mg/dL, AST to 85 U/L, and ALT to 90 U/L, indicating worsening liver function. In response to these findings, the care team initiates treatment with lactulose to reduce ammonia levels and considers the addition of rifaximin for more long-term management. This adjustment is critical to prevent further neurological deterioration and to stabilize the patient's hepatic function.
The patient's vital signs show a slight improvement, with heart rate decreasing to 98 bpm, but blood pressure remains low at 96/64 mmHg. Despite these challenges, the patient continues to be supported with IV fluids to maintain hemodynamic stability. The team remains vigilant, recognizing that the management of hepatic complications requires a delicate balance of treatments that address both the GI bleed and liver dysfunction. As the patient's care plan evolves, the team emphasizes the importance of comprehensive monitoring and readiness to adapt strategies in response to the patient's changing condition. This situation underscores the complexity of managing multiple interrelated issues and the necessity for integrated clinical reasoning in guiding the patient's ongoing care.